# Endovenous Versus Liposomal Iron in CKD

Study · id `cardio:ct-nct01864161` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01864161](<https://clinicaltrials.gov/study/NCT01864161>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01864161

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT01864161. Randomized; no masking; primary purpose treatment. Start 2011-10 (registry gives no type); primary completion 2013-05 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT01864161, source copy `cardio:ctgov-nct01864161-2014-07-24`, retrieved 2026-10-26)
- Start date: 2011-10 (registry gives no type) (ClinicalTrials.gov record NCT01864161, source copy `cardio:ctgov-nct01864161-2014-07-24`, retrieved 2026-10-26)
- Primary completion: 2013-05 (actual) (ClinicalTrials.gov record NCT01864161, source copy `cardio:ctgov-nct01864161-2014-07-24`, retrieved 2026-10-26)
- Completion: 2013-05 (actual) (ClinicalTrials.gov record NCT01864161, source copy `cardio:ctgov-nct01864161-2014-07-24`, retrieved 2026-10-26)
- Countries: Italy (ClinicalTrials.gov record NCT01864161, source copy `cardio:ctgov-nct01864161-2014-07-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01864161-2014-07-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Endovenous Versus Liposomal Iron in CKD
- Condition: Iron Deficiency Anemia
- Condition: Chronic Kidney Disease
- Intervention (Drug): gluconate iron
- Intervention (Drug): Liposomal iron
- Lead sponsor: Federico II University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Federico II University (`cardio:org-federico-ii-university`)

## Provenance

Content hash: e974d201ed67dce0b54b64a8a518480b1810374f5e1807f4512fb2a3ca71cc76
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
